📰00The next era of healthcare is personalMcKinsey Insights & Publications·The next era of healthcare is personal·4 days ago#4jWwus8M#mckinsey#moderna#phane#bancel#explains#mrna+3 more🧰Tag tools✨Add tagModerna CEO Stéphane Bancel explains how mRNA, AI, and individualized care could transform everything from vaccines to cancer treatment.15s0Read later0Read More
🖼️00A New Hantavirus Vaccine Is in the WorksWIRED·Javier Carbajal·21 days ago#zUJpjW4p#intcid#vaccines#publichealth#diseases#vaccine#hantavirus+4 more🧰Tag tools✨Add tagSince 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.15s0Read later0Read More
🖼️00Hantavirus cases spark surge in pharma and biotech stocks — here’s whyCNBC·Sawdah Bhaimiya·22 days ago#wUDQRkPj#pharmaceuticals#business#healthcareindustry#vaccinations#hantavirus#outbreak+5 more🧰Tag tools✨Add tagThe outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.15s0Read later0Read More
🖼️00Moderna's Post-COVID Collapse: Pipeline Risks & Cash Burn ExplainedSeeking Alpha·Seeking Alpha Videos·29 days ago#ZAbJy8tV#source#chevron#alpha#moderna#seeking#covid+4 more🧰Tag tools✨Add tagWhy is Moderna losing billions after COVID? Stephen Ayers breaks down pipeline risks, RSV competition, cash burn, and what's next for the stock.15s0Read later0Read More
📰00Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccineArs Technica·Beth Mole·about 1 month ago#lz6oisug#section#theme#text#ars#arrow#vaccine+6 more🧰Tag tools✨Add tagFrom Ars Technica: Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine15s0Read later0Read More
